Immunotherapy for Solitary Fibrous Tumor (Hemangiopericytoma)

The presence of somatic DNA repair enzyme gene mutations in SFT may suggest a benefit from a combination of radiotherapy and immunotherapy. This may serve as a biomarker for guiding management in patients with this rare tumor.